Co-Diagnostics (CODX) Live Share Price, Invest From India

Co-Diagnostics Stock Performance

as on August 27, 2026 at 6:59 am IST

Day's Low
Day's High
$1.22
Day's Price Range
$1.27
$1.25
2.40%
Downside
1.60%
Upside
52 Week's Low
52 Week's High
$0.94
52-Week Price Range
$46.50
$1.25
24.83%
Downside
3620.00%
Upside

Co-Diagnostics share price movements today

Previous Close: $1.23
Open: $1.23
Volume: 175.9K
Market Cap: $7.6M
Day's Low - High: $1.22 - $1.27
52 Week Low - High: $0.94 - $46.50

Co-Diagnostics Historical Returns

1 Month Return: -39.71 %
3 Month Return: -83.15 %
1 Year Return: -87.42 %
3 Year Return: -96.55 %
5 Year Return: -99.62 %

Co-Diagnostics Stock Fundamentals & Key Indicators

Check Co-Diagnostics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.6M

EPS (TTM)

-3.1

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.31%

PE Ratio (TTM)

PEG Ratio

EBITDA

-29.1M

Revenue (TTM)

721.4K

Profit Margin

0.00%

Return On Equity TTM

-174.77%

Co-Diagnostics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Co-Diagnostics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Co-Diagnostics	SELL	$7.6M	-99.62%	NA	0.00%	NA
Edwards Lifesciences	BUY	$52.2B	-21.93%	53.55	15.43%	NA
Stryker	BUY	$125.7B	20.91%	34.15	14.43%	105.3%
Abbott Laboratories	BUY	$201.9B	-6.79%	37.76	11.65%	213.54999999999998%
Medtronic	BUY	$118.9B	-31.89%	24.97	13.20%	312.71%

See all

Stock Returns calculator for Co-Diagnostics Stock including INR - Dollar returns

The Co-Diagnostics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Co-Diagnostics investment value today

Current value as on today

₹13,914

Returns

-₹86,086

(-86.09%)

Returns from Co-Diagnostics Stock

-₹87,219 (-87.22%)

Dollar Impact

₹1,133 (+1.13%)

Analyst Recommendation on Co-Diagnostics Stock

Based on 1 analysts

SELL

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'SELL' rating for Co-Diagnostics. Average target price of $4

Co-Diagnostics Share Price Target

Get share price movements and forecasts by analysts on Co-Diagnostics.

What analysts predicted

68.75%UPSIDE

Target Price

Current Price

$1.25

Analyzed by

1 Analysts

Target

$4.00

Co-Diagnostics target price $4, a slight upside of 68.75% compared to current price of $1.25. According to 1 analysts rating.

Indian Investors' Interest in Co-Diagnostics Stock

Search interest for Co-Diagnostics Stock has increased by 1% in the last 30 days, reflecting an upward trend in search activity.

Time period: July 28, 2026 to August 27, 2026

Change:1% versus previous 30 day period

Co-Diagnostics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	0	2	0	0	0	0	0	0	0	0
Gross Profit	0	2	0	0	0	0	0	0	0	0
Operating Income	-10	-7	-10	-11	-8	-8	-7	-7	-9	-6
EBITDA	-8	-7	-9	-10	-7	-7	-6	-25	-8	-5
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	-
Income Before Tax	-9	-7	-9	-11	-7	-7	-7	-26	-9	-6
Income Tax Expense	0	0	0	0	0	0	-1	0	0	0
Net Income	-9	-7	-9	-11	-7	-7	-5	-25	-9	-6
Net Profit Margin	-3684.36%	-286.03%	-1512.37%	-7387.37%	-14983.53%	-4745.02%	-4049.27%	-9755.05%	-6262.27%	-3782.43%

Co-Diagnostics Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	0	0	0	74	97	34	6	3	0
Gross Profit	0	0	0	0	57	86	28	2	2	0
Operating Income	-1	-4	-6	-5	41	46	-26	-42	-40	-31
EBITDA	-1	-6	-6	-6	41	45	-10	-36	-36	-47
Interest Expense	0	0	0	0	0	0	14	-	-	-
Depreciation	-	0	0	0	0	0	1	1	1	1
Income Before Tax	-1	-6	-6	-6	42	45	-18	-38	-37	-48
Income Tax Expense	-	0	0	0	0	8	-4	-2	0	-1
Net Income	-1	-6	-6	-6	42	36	-14	-35	-37	-46
Net Profit Margin	0.00%	-90827.88%	-15714.27%	-2882.00%	56.98%	37.45%	-41.61%	-518.68%	-961.37%	-7533.62%

Co-Diagnostics Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-7	-9	-11	-7	-7	-5	-25	-9	-6
Operating Cash Flow	-5	-7	-8	-8	-8	-5	-6	-7	-7
Investing Cash Flow	-4	4	0	7	17	2	0	0	0
Financing Cash Flow	-	-	0	0	0	4	6	4	2
Change in Cash	-9	-3	-7	-1	9	0	0	-3	-4

Co-Diagnostics Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-6	-6	-6	42	36	-14	-35	-37	-46
Operating Cash Flow	-3	-4	-5	28	41	6	-22	-29	-29
Investing Cash Flow	0	0	0	-5	4	-58	15	17	26
Financing Cash Flow	5	1	5	19	0	-14	-1	0	11
Change in Cash	2	-2	0	42	45	-65	-8	-11	8

Mutual Funds that own Co-Diagnostics Stock

Check out the Mutual Funds with significant holdings in Co-Diagnostics.

Funds	Holdings	Shares Held
Bridgeway Funds, Inc.	0.519807%	32500
Victory Portfolios III	0.054843%	3429
Fidelity Concord Street Trust	0.000623%	39

Global Institutional Holdings in Co-Diagnostics

Funds	Holdings
Vanguard	0.93%

Co-Diagnostics News & Key Events

Insights on Co-Diagnostics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -25.74M → -6.28M (in $), with an average increase of 113.6% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, CODX stock has moved up by 7.0%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 145.95K → 166.13K (in $), with an average increase of 12.2% per quarter
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp has given 12.3% return, outperforming this stock by 99.7%
NO EFFECT
Against Peers
In the last 3 years, Edwards Lifesciences Corp has given 19.3% return, outperforming this stock by 115.9%

About Co-Diagnostics

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.

Organisation	Co-Diagnostics
Headquarters	2401 S. Foothill Drive, Salt Lake City, UT, United States, 84109
Industry	Medical Devices
CEO	Mr. Dwight H. Egan
E-voting on shares	Click here to vote

Key Management of Co-Diagnostics

Name	Title
Mr. Dwight H. Egan	Chairman, CEO & President
Mr. David Nielsen	Chief Operating Officer
Mr. Seth Egan	Chief Commercialization Officer & Strategy Officer
Mr. Richard David Abbott	President
Mr. Brian L. Brown CPA	CFO & Company Secretary
Mr. Dan Bohrer CPA	Vice President of Finance & Accounting
Mr. Christopher Thurston	Chief Technology Officer
Dr. Wesley C. Lindsey MBA, Ph.D.	Chief Scientific Officer
Mr. Andrew Benson	Head of Investor Relations
Dr. Mayuranki Almaula Ph.D.	Senior Vice President of Overseas Operations & Strategic Alliances

FAQs

What is Co-Diagnostics share price today?

Co-Diagnostics share price today is $1.25 as on August 27, 2026 at 1:29 am IST at the close of the market. Co-Diagnostics share today touched a day high of $1.27 and a low of $1.22.

What is the 52 week high and 52 week low for Co-Diagnostics share?

Co-Diagnostics share touched a 52 week high of $46.50 on January 1, 1970 and a 52 week low of $0.94 on January 1, 1970. Co-Diagnostics stock price today i.e. August 27, 2026 at 1:29 am IST is closed at $1.25,which is 97.31% down from its 52 week high and 33.04% up from its 52 week low.

What is Co-Diagnostics's market capitalisation today?

Co-Diagnostics market capitalisation is $0.00T as on August 27, 2026 at 1:29 am IST.

How to invest in Co-Diagnostics Stock (CODX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Co-Diagnostics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Co-Diagnostics Shares that will get you 1.2000 shares as per Co-Diagnostics share price of $1.25 per share as on August 27, 2026 at 1:29 am IST.

What is the minimum amount required to buy Co-Diagnostics Stock (CODX) from India?

Indian investors can start investing in Co-Diagnostics (CODX) shares with as little as ₹95.402 or $1 (as of August 27, 2026 at 7:05 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹954.02 in Co-Diagnostics stock (as per the Rupee-Dollar exchange rate as on August 27, 2026 at 7:05 am IST). Based on Co-Diagnostics share’s latest price of $1.25 as on August 27, 2026 at 1:29 am IST, you will get 8.0000 shares of Co-Diagnostics. Learn more about fractional shares .

What are the returns that Co-Diagnostics has given to Indian investors in the last 5 years?

Co-Diagnostics stock has given -99.62% share price returns and 29.12% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?